Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impact of Lead-shielding on the Utilization of Magnetic Resonance Imaging Among Patients with Spinal Cord Stimulation Systems: A Study of Retrospective Claims in the US.
Journal: Pain physician
Published: January 02, 2026
MRI for in vivo Analysis of Ablation Zones Formed by Cooled Radiofrequency Neurotomy to Treat Chronic Joint Pain Across Multiple Axial Spine Sites.
Journal: Journal of pain research
Published: October 05, 2021
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.
Journal: Radiology
Published: November 28, 2018
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
Journal: Neuro-oncology
Published: March 29, 2018
The Rate of Magnetic Resonance Imaging in Patients with Deep Brain Stimulation.
Journal: Stereotactic and functional neurosurgery
Published: February 17, 2016
Shared Decision-Making: Evaluating the Evidence for Access to MR-Conditional Devices to Allow Patients and Providers to Make Informed and Collaborative Choices in the 21st Century.
Journal: Neuromodulation : journal of the International Neuromodulation Society
Published: June 03, 2015
The rate of magnetic resonance imaging in patients with spinal cord stimulation.
Journal: Spine
Published: February 04, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.
Journal: International journal of oncology
Published: November 20, 2014
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
Journal: Neuro-oncology
Published: May 07, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026